Schonfeld Strategic Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
AC
VCM
VPM
Schonfeld Strategic Advisors's AVNS Position: Q1 2026 in Review
Schonfeld Strategic Advisors sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 10,824 shares — an estimated $122K sold.
Schonfeld Strategic Advisors first reported a position in AVNS in Q3 2017 and held it in 13 quarters. The position peaked at $8.59M in Q2 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Schonfeld Strategic Advisors reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 10,824 Avanos Medical shares in Q1 2026, an estimated $122K.
- Schonfeld Strategic Advisors first reported a position in Avanos Medical in Q3 2017 and held it in 13 quarters.
- Schonfeld Strategic Advisors's Avanos Medical position peaked at $8.59M in Q2 2018.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.